Australia and New Zealand Endotoxin Testing Market Report and Forecast 2024-2032
Market Report (7 days) I 2024-02-12 I 120 Pages I EMR Inc.
Australia and New Zealand Endotoxin Testing Market Report and Forecast 2024-2032
Australia and New Zealand Endotoxin Testing Market Outlook
The Australia and New Zealand endotoxin testing market size is anticipated to grow at a CAGR of 9.5% during the forecast period of 2024-2032, driven by the increase in development of innovative, rapid, and sensitive testing methods.
Endotoxin Testing: Introduction
Endotoxin testing is a critical quality control process in pharmaceutical and medical device manufacturing, ensuring products are free from endotoxins, toxic substances released by certain bacteria. The presence of endotoxins can lead to severe reactions such as fever, septic shock, and other complications. The most common method for endotoxin testing is the Limulus Amebocyte Lysate (LAL) test, which utilizes the blood cells of horseshoe crabs to detect endotoxins with high sensitivity and specificity.
Key Trends in the Australia and New Zealand Endotoxin Testing Market
Stringent regulations by healthcare authorities worldwide to ensure drug safety and efficacy, mandating rigorous endotoxin testing. Development of innovative, rapid, and sensitive testing methods to enhance accuracy and reduce turnaround time.
Increasing adoption of automated systems for endotoxin testing, improving efficiency and reproducibility while reducing human error. Growth in the biopharmaceutical sector leads to an increased need for endotoxin testing of biologically derived products, including vaccines and cell therapies.
Heightened focus on drug safety due to global health challenges, such as the COVID-19 pandemic, amplifying the importance of rigorous contamination control.
Efforts to find sustainable alternatives to the traditional LAL test, addressing the conservation concerns related to horseshoe crab harvesting.
Australia and New Zealand Endotoxin Testing Market Segmentation
Market Breakup by Product and Services
- Endotoxin Detection Kits and Reagents
- Instruments, Systems, and Software
- Endotoxin Testing Services
- Consumables and Accessories
Market Breakup by Test Type
- Limulus Amoebocyte Lysate (LAL) Test
- Monocyte Activation Test (MAT)
- Rabbit Pyrogen Test and Recombinant C (RFC) Assay
Market Breakup by Distribution Channel
- Pharmacies
- Online Channel
- Hypermarkets
Market Breakup by Method
- Gel Clot Endotoxin Test
- Chromogenic Endotoxin Test
- Turbidimetric Endotoxin Test
Market Breakup by Mode of Purchase
- Large Group
- Mid and Small Group
- Individual
Market Breakup by Applications
- Pharmaceutical Manufacturing
- Medical Device Manufacturing
- Raw Materials Production
- Packaging Manufacture
Market Breakup by End User
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Companies
- Contract Research Organization (CRO)
- Contract Manufacturing Organization (CMO)
- Academic Research Institute and Others
Market Breakup by Country
- Australia
- New Zealand
Australia and New Zealand Endotoxin Testing Market Overview
In Australia, the endotoxin testing market is characterized by stringent regulatory standards and a robust biotechnology sector. Strong emphasis on meeting the Therapeutic Goods Administration (TGA) guidelines for product safety, driving the demand for rigorous endotoxin testing. Adoption of advanced testing technologies and automation to increase efficiency and accuracy in endotoxin detection. Expansion of the pharmaceutical and biotechnology sectors, increasing the need for quality control measures including endotoxin testing. Increasing awareness about product safety among manufacturers and consumers, leading to a proactive approach in quality assurance practices.
In New Zealand, the market for endotoxin testing reflects the country's commitment to high-quality healthcare products. High healthcare standards driving the need for strict quality control in pharmaceuticals and medical devices, including endotoxin testing.\ Significant investment in research and development within the biotech sector, necessitating reliable endotoxin testing to ensure product safety and efficacy. Collaboration between academic institutions, research labs, and the biotech industry, fostering advancements in testing methods and technologies. A growing trend towards adopting sustainable and ethical practices in testing, including alternatives to traditional methods that reduce reliance on animal-derived substances like LAL.
Australia and New Zealand Endotoxin Testing Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
- Viatris Inc.
- Eurofins Scientific
- Thermo Fisher Scientific
- Pall Corporation.
- Lonza Group AG
- Charles River Laboratories
- Merck KGaASteris Inc.
- Societe Generale de Surveillance SA
- Sartorius AG
- GenScript
- Accugen Labs
- Sigma-Aldrich
- Nelson Laboratories and Biosynthesis
- Pacific BioLabs
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Australia and New Zealand Endotoxin Testing Market Overview
3.1 Australia and New Zealand Endotoxin Testing Market Historical Value (2017-2023)
3.2 Australia and New Zealand Endotoxin Testing Market Forecast Value (2024-2032)
4 Australia and New Zealand Endotoxin Testing Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter's Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Australia and New Zealand Endotoxin Testing Market Segmentation
5.1 Australia and New Zealand Endotoxin Testing Market by Product & Services
5.1.1 Market Overview
5.1.2 Endotoxin Detection Kits & Reagents
5.1.3 Instruments, Systems, and Software
5.1.4 Endotoxin Testing Services
5.1.5 Consumables & Accessories
5.2 Australia and New Zealand Endotoxin Testing Market by Test Type
5.2.1 Market Overview
5.2.2 Limulus Amoebocyte Lysate (LAL) Test
5.2.3 Monocyte Activation Test (MAT)
5.2.4 Rabbit Pyrogen Test and Recombinant C (RFC) Assay
5.3 Australia and New Zealand Endotoxin Testing Market by Distribution Channel
5.3.1 Market Overview
5.3.2 Pharmacies
5.3.3 Online Channel
5.3.4 Hypermarkets
5.4 Australia and New Zealand Endotoxin Testing Market by Method
5.4.1 Market Overview
5.4.2 Gel Clot Endotoxin Test
5.4.3 Chromogenic Endotoxin Test
5.4.4 Turbidimetric Endotoxin Test
5.5 Australia and New Zealand Endotoxin Testing Market by Mode of Purchase
5.5.1 Market Overview
5.5.2 Large Group
5.5.3 Mid and Small Group
5.5.4 Individual
5.6 Australia and New Zealand Endotoxin Testing Market by Applications
5.6.1 Market Overview
5.6.2 Pharmaceutical Manufacturing
5.6.3 Medical Device Manufacturing
5.6.4 Raw Materials Production
5.6.5 Packaging Manufacture
5.7 Australia and New Zealand Endotoxin Testing Market by End User
5.7.1 Market Overview
5.7.2 Pharmaceutical Companies
5.7.3 Biotechnology Companies
5.7.4 Medical Device Companies
5.7.5 Contract Research Organization (CRO)
5.7.6 Contract Manufacturing Organization (CMO)
5.7.7 Academic Research Institute and Others
5.8 Australia and New Zealand Endotoxin Testing Market by Country
5.8.1 Market Overview
5.8.2 Australia
5.8.3 New Zealand
6 Patent Analysis
6.1 Analysis by Type of Patent
6.2 Analysis by Publication year
6.3 Analysis by Issuing Authority
6.4 Analysis by Patent Age
6.5 Analysis by CPC Analysis
6.6 Analysis by Patent Valuation
6.7 Analysis by Key Players
7 Grants Analysis
7.1 Analysis by year
7.2 Analysis by Amount Awarded
7.3 Analysis by Issuing Authority
7.4 Analysis by Grant Application
7.5 Analysis by Funding Institute
7.6 Analysis by NIH Departments
7.7 Analysis by Recipient Organization
8 Funding Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography
9 Partnership and Collaborations Analysis
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Partnership
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Regulatory Framework
10.1 Regulatory Overview
11 Supplier Landscape
11.1 Viatris Inc.
11.1.1 Financial Analysis
11.1.2 Product Portfolio
11.1.3 Demographic Reach and Achievements
11.1.4 Mergers and Acquisitions
11.1.5 Certifications
11.2 Eurofins Scientific
11.2.1 Financial Analysis
11.2.2 Product Portfolio
11.2.3 Demographic Reach and Achievements
11.2.4 Mergers and Acquisitions
11.2.5 Certifications
11.3 Thermo Fisher Scientific
11.3.1 Financial Analysis
11.3.2 Product Portfolio
11.3.3 Demographic Reach and Achievements
11.3.4 Mergers and Acquisitions
11.3.5 Certifications
11.4 Pall Corporation.
11.4.1 Financial Analysis
11.4.2 Financial Portfolio
11.4.3 Demographic Reach and Achievements
11.4.4 Mergers and Acquisitions
11.4.5 Certifications
11.5 Lonza Group AG
11.5.1 Financial Analysis
11.5.2 Product Portfolio
11.5.3 Demographic Reach and Achievements
11.5.4 Mergers and Acquisitions
11.5.5 Certifications
11.6 Charles River Laboratories
11.6.1 Financial Analysis
11.6.2 Product Portfolio
11.6.3 Demographic Reach and Achievements
11.6.4 Mergers and Acquisitions
11.6.5 Certifications
11.7 Merck KGaA
11.7.1 Financial Analysis
11.7.2 Product Portfolio
11.7.3 Demographic Reach and Achievements
11.7.4 Mergers and Acquisitions
11.7.5 Certifications
11.8 Steris Inc.
11.8.1 Financial Analysis
11.8.2 Product Portfolio
11.8.3 Demographic Reach and Achievements
11.8.4 Mergers and Acquisitions
11.8.5 Certifications
11.9 Societe Generale de Surveillance SA
11.9.1 Financial Analysis
11.9.2 Product Portfolio
11.9.3 Demographic Reach and Achievements
11.9.4 Mergers and Acquisitions
11.9.5 Certifications
11.10 Sartorius AG
11.10.1 Financial Analysis
11.10.2 Product Portfolio
11.10.3 Demographic Reach and Achievements
11.10.4 Mergers and Acquisitions
11.10.5 Certifications
11.11 GenScript
11.11.1 Financial Analysis
11.11.2 Product Portfolio
11.11.3 Demographic Reach and Achievements
11.11.4 Mergers and Acquisitions
11.11.5 Certifications
11.12 Accugen Labs
11.12.1 Financial Analysis
11.12.2 Product Portfolio
11.12.3 Demographic Reach and Achievements
11.12.4 Mergers and Acquisitions
11.12.5 Certifications
11.13 Sigma-Aldrich
11.13.1 Financial Analysis
11.13.2 Product Portfolio
11.13.3 Demographic Reach and Achievements
11.13.4 Mergers and Acquisitions
11.13.5 Certifications
11.14 Nelson Laboratories and Biosynthesis
11.14.1 Financial Analysis
11.14.2 Product Portfolio
11.14.3 Demographic Reach and Achievements
11.14.4 Mergers and Acquisitions
11.14.5 Certifications
11.15 Pacific BioLabs
11.15.1 Financial Analysis
11.15.2 Product Portfolio
11.15.3 Demographic Reach and Achievements
11.15.4 Mergers and Acquisitions
11.15.5 Certifications
12 Australia and New Zealand Endotoxin Testing Market - Distribution Model (Additional Insight)
12.1 Overview
12.2 Potential Distributors
12.3 Key Parameters for Distribution Partner Assessment
13 Key Opinion Leaders (KOL) Insights (Additional Insight)
14 Company Competitiveness Analysis (Additional Insight)
14.1 Very Small Companies
14.2 Small Companies
14.3 Mid-Sized Companies
14.4 Large Companies
14.5 Very Large Companies
15 Payment Methods (Additional Insight)
15.1 Government Funded
15.2 Private Insurance
15.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.